BRIDGE is a funding programme of the SNSF and Innosuisse. Together, we have been funding projects between basic research and innovation since 2017. BRIDGE thus complements our other funding offers.
Support is provided to researchers whose results have potential for an innovative product or service. However, further work is needed to clearly determine the potential. The BRIDGE contributions make this possible. In this way, they accelerate the transfer of research results into the economy and society.
Proof of Concept is aimed at young researchers, Discovery at experienced researchers from all disciplines. We are investing 105 million Swiss francs in BRIDGE projects between 2021 and 2024.
Elected by the SNSF and Innosuisse, the Steering Committee is responsible for the successful implementation of the programme. Its members come from research, industry and public administration. Operational management is entrusted to the BRIDGE Office. The Steering Committee has appointed two evaluation panels of experts to assess the applications.
Organigram (* Presiding Board of the SNSF National Research Council / ** Innosuisse Board)
et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
- David Brown (Innosuisse, loganbrown)
- Nicoletta Casanova (Innosuisse, FEMTOprint) (chair)
- Mirjam Christ-Crain (SNSF, UniBS)
- Mariana Christen Jakob (seif)
- Bernd Gotsmann (SNSF, IBM Research)
- Penny Schiffer (Raized.AI)
- Götz Schlotterbeck (Canton of Basel-Stadt)
- David Brown (loganbrown) (chair)
- Urs Bucher (Kalaidos)
- Alex Dommann (UniBE)
- Regine Eibl-Schindler (ZHAW)
- Lisa Falco (Zühlke Group)
- Olga Fink (EPFL)
- Paola Ghillani (Paola Ghillani & Friends)
- Greta Guarda (USI)
- Anja Harmeier (Rewind Therapeutics)
- Christofer Hierold (ETHZ)
- Daniele Inaudi (Roctest)
- Karl-Heinz Krause (Neurix SA)
- Teodoro Laino (IBM Research)
- James Miners (Fongit)
- Samantha Paoletti (CSEM)
- Lesley Spiegel (ad hoc member, DIZH)
- Jakob Rhyner (University Bonn) (chair)
- Kaspar Binz (Binz Biotech Consulting)
- Marc Bohner (RMS Foundation)
- Emine Cagin (Heidelberg Instruments Nano)
- Claude Clément (Freelance)
- Alke Fink (UniFR)
- Luca Maria Gambardella (USI, IDSIA, Artificialy SA)
- Helmut Grabner (ZHAW)
- Ursula Graf-Hausner (ZHAW, 3dcellculture)
- Pierangelo Groening (EMPA)
- Wolfgang Haap (Roche)
- Naomi Häfner (UniSG)
- Emanuela Keller (UniZH)
- Anne-Marie Kermarrec (EPFL)
- Stéphane Marchand-Maillet (UniGE)
- André Mercanzini (Aleva Neurotherapeutics)
- Christine Mohr (UniLA)
- Giuseppe Perale (USI, IBI SA)
- Yves Perriard (EPFL)
- Dimos Poulikakos (ETHZ)
- Sven Schimpf (Fraunhofer IAO)
- Göran Stemme (KTH)
- Stefan Weber (UniBE)
- Stephen Wittkopf (HSLU)
- Hans-Florian Zeilhofer (UniBS)